|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bourne TD and Schiff D: Update on
molecular findings, management and outcome in low-grade gliomas.
Nat Rev Neurol. 6:695–701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poleszczuk J, Hahnfeldt P and Enderling H:
Therapeutic implications from sensitivity analysis of tumor
angiogenesis models. PLoS One. 10:e01200072015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao Z, Cheng P, Xue Y and Liu Y: Vascular
endothelial growth factor participates in modulating the C6
glioma-induced migration of rat bone marrow-derived mesenchymal
stem cells and upregulates their vascular cell adhesion molecule-1
expression. Exp Ther Med. 4:993–998. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Damert A, Machein M, Breier G, Fujita MQ,
Hanahan D, Risau W and Plate KH: Up-regulation of vascular
endothelial growth factor expression in a rat glioma is conferred
by two distinct hypoxia-driven mechanisms. Cancer Res.
57:3860–3864. 1997.PubMed/NCBI
|
|
10
|
Jensen RL: Growth factor-mediated
angiogenesis in the malignant progression of glial tumors: A
review. Surg Neurol. 49:189–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim TY, Kim J, Choo HY and Kwon HJ:
Inhibition of 5-lipoxygenase suppresses vascular endothelial growth
factor-induced angiogenesis in endothelial cells. Biochem Biophys
Res Commun. 478:1117–1122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim KJ, Li B, Winer J, Armanini M, Gillett
N, Phillips HS and Ferrara N: Inhibition of vascular endothelial
growth factor-induced angiogenesis suppresses tumour growth in
vivo. Nature. 362:841–844. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li R and Li X, Ning S, Ye J, Han L, Kang C
and Li X: Identification of a core miRNA-pathway regulatory network
in glioma by therapeutically targeting miR-181d, miR-21, miR-23b,
β-Catenin, CBP, and STAT3. PLoS One. 9:e1019032014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Yin F, Zhang J, Wicha MS, Chang AE,
Fan W, Chen L, Fan M and Li Q: Regulatory roles of miRNA in the
human neural stem cell transformation to glioma stem cells. J Cell
Biochem. 115:1368–1380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao W, Guo G, Zhang Q, Fan L, Wu N and Bo
Y: The application of multiple miRNA response elements enables
oncolytic adenoviruses to possess specificity to glioma cells.
Virology. 458–459:69–82. 2014. View Article : Google Scholar
|
|
16
|
Ciafré SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu D, Han L, Wu X, Yang X, Zhang Q and
Jiang F: Genome-wide microRNA changes in human intracranial
aneurysms. BMC Neurol. 14:1882014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K,
Xu H and Jiang S: miR-24-3p and miR-27a-3p promote cell
proliferation in glioma cells via cooperative regulation of MXI1.
Int J Oncol. 42:757–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen L, Zhang A, Li Y, Zhang K, Han L, Du
W, Yan W, Li R, Wang Y, Wang K, et al: MiR-24 regulates the
proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4
signaling. Cancer Lett. 329:174–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan Z, Liu J, Xie L, Liu X and Zeng Y:
Role of heparan sulfate in mediating CXCL8-induced endothelial cell
migration. Peer J. 4:e16692016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng Y, Liu XH, Tarbell J and Fu B:
Sphingosine 1-phosphate induced synthesis of glycocalyx on
endothelial cells. Exp Cell Res. 339:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng Y and Liu J: Role of glypican-1 in
endothelial NOS activation under various steady shear stress
magnitudes. Exp Cell Res. 348:184–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang N, Jain RK and Batchelor TT: New
directions in anti-angiogenic therapy for glioblastoma.
Neurotherapeutics. 14:321–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seystahl K, Wick W and Weller M:
Therapeutic options in recurrent glioblastoma-an update. Crit Rev
Oncol Hematol. 99:389–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Codrici E, Enciu AM, Popescu ID, Mihai S
and Tanase C: Glioma stem cells and their microenvironments:
Providers of challenging therapeutic targets. Stem Cells Int.
2016:57284382016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui L, Xu S, Song Z, Zhao G, Liu X and
Song Y: Pituitary tumor transforming gene: A novel therapeutic
target for glioma treatment. Acta Biochim Biophys Sin (Shanghai).
47:414–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Yang L, Teng X and Liu Z, Liu C,
Zhang L and Liu Z: The chemokine receptor CXCR7 is a critical
regulator for the tumorigenesis and development of papillary
thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Tumour Biol. 37:2415–2423. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Desjardins A, Reardon DA, Herndon JE II,
Marcello J, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S,
Sampson J, Bailey L, et al: Bevacizumab plus irinotecan in
recurrent WHO grade 3 malignant gliomas. Clin Cancer Res.
14:7068–7073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gondi CS, Lakka SS, Dinh DH, Olivero WC,
Gujrati M and Rao JS: Downregulation of uPA, uPAR and MMP-9 using
small, interfering, hairpin RNA (siRNA) inhibits glioma cell
invasion, angiogenesis and tumor growth. Neuron Glia Biol.
1:165–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Niola F, Evangelisti C, Campagnolo L,
Massalini S, Buè MC, Mangiola A, Masotti A, Maira G, Farace MG and
Ciafrè SA: A plasmid-encoded VEGF siRNA reduces glioblastoma
angiogenesis and its combination with interleukin-4 blocks tumor
growth in a xenograft mouse model. Cancer Biol Ther. 5:174–179.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu R, Zhang H, Wang X, Zhou L, Li H, Deng
T, Qu Y, Duan J, Bai M, Ge S, et al: The miR-24-Bim pathway
promotes tumor growth and angiogenesis in pancreatic carcinoma.
Oncotarget. 6:43831–43842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiuju C, Zhen W and Yanchao S: SOX7
inhibits tumor progression of glioblastoma and is regulated by
miRNA-24. Open Med (Wars). 11:133–137. 2016.PubMed/NCBI
|
